NHS GREATER GLASGOW AND CLYDE
Audio Technology To Detect Lung Cancer Earlier
- Conditions
- Interventions
- First Posted Date
- 2018-06-25
- Last Posted Date
- 2018-06-25
- Lead Sponsor
- NHS Greater Glasgow and Clyde
- Target Recruit Count
- 20
- Registration Number
- NCT03566862
- Locations
- π¬π§
Queen Elizabeth University Hospital Glasgow, Glasgow, United Kingdom
Endothelial Effects of VEGF Inhibition In Vivo in Man
- Conditions
- First Posted Date
- 2018-06-14
- Last Posted Date
- 2019-11-26
- Lead Sponsor
- NHS Greater Glasgow and Clyde
- Target Recruit Count
- 56
- Registration Number
- NCT03557190
- Locations
- π¬π§
Queen Elizabeth University Hospital, Glasgow, United Kingdom
Intermediate and Long Term Vascular Effects of Cisplatin in Patients With Testicular Cancer
- Conditions
- First Posted Date
- 2018-06-14
- Last Posted Date
- 2019-11-25
- Lead Sponsor
- NHS Greater Glasgow and Clyde
- Target Recruit Count
- 37
- Registration Number
- NCT03557164
- Locations
- π¬π§
Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom
Clinical Characterisation of the Vascular Effects of Cis-platinum Based Chemotherapy in Patients With Testicular Cancer
- Conditions
- First Posted Date
- 2018-06-14
- Last Posted Date
- 2019-11-25
- Lead Sponsor
- NHS Greater Glasgow and Clyde
- Target Recruit Count
- 36
- Registration Number
- NCT03557177
- Locations
- π¬π§
Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom
The Effects of Sacubitril/Valsartan Compared to Valsartan on LV Remodelling in Asymptomatic LV Systolic Dysfunction After MI
- First Posted Date
- 2018-06-12
- Last Posted Date
- 2023-05-03
- Lead Sponsor
- NHS Greater Glasgow and Clyde
- Target Recruit Count
- 93
- Registration Number
- NCT03552575
- Locations
- π¬π§
Glasgow Cardiovascular Research Centre, Glasgow, Scotland, United Kingdom
π¬π§Glasgow Clinical Research Facility, Glasgow, Scotland, United Kingdom
Studies of Empagliflozin and Its Cardiovascular, Renal and Metabolic Effects
- Conditions
- Interventions
- First Posted Date
- 2018-04-02
- Last Posted Date
- 2020-09-18
- Lead Sponsor
- NHS Greater Glasgow and Clyde
- Target Recruit Count
- 105
- Registration Number
- NCT03485092
- Locations
- π¬π§
Queen Elizabeth University Hospital, Glasgow, Scotland, United Kingdom
Perfluorocarbon (ABL-101) Oxygenation for Stroke: Trial With GOLD (Glasgow Oxygen Level Dependent Technology) Imaging Theranostic
- First Posted Date
- 2018-03-13
- Last Posted Date
- 2018-08-02
- Lead Sponsor
- NHS Greater Glasgow and Clyde
- Target Recruit Count
- 18
- Registration Number
- NCT03463551
Propofol Target-Controlled Infusion in Emergency Department Sedation
- First Posted Date
- 2018-02-22
- Last Posted Date
- 2018-02-22
- Lead Sponsor
- NHS Greater Glasgow and Clyde
- Target Recruit Count
- 20
- Registration Number
- NCT03442803
- Locations
- π¬π§
Glasgow Royal Infirmary, Glasgow, United Kingdom
π¬π§Queen Elizabeth University Hospital, Glasgow, United Kingdom
π¬π§Royal Alexandra Hospital, Paisley, United Kingdom
Immune Metabolic Associations in Psoriatic Arthritis
- Conditions
- First Posted Date
- 2018-01-16
- Last Posted Date
- 2019-11-25
- Lead Sponsor
- NHS Greater Glasgow and Clyde
- Target Recruit Count
- 60
- Registration Number
- NCT03399708
- Locations
- π¬π§
Glasgow Royal Infirmary, Glasgow, Scotland, United Kingdom
The Cardiovascular Impacts of Electronic Cigarettes in Comparison to the Use of Nicotine Replacement Patches
- Conditions
- Interventions
- First Posted Date
- 2017-12-02
- Last Posted Date
- 2018-09-18
- Lead Sponsor
- NHS Greater Glasgow and Clyde
- Target Recruit Count
- 55
- Registration Number
- NCT03358953
- Locations
- π¬π§
Glasgow Clinical Research Facility, Glasgow, Scotland, United Kingdom